US Stock MarketDetailed Quotes
VNDA Vanda Pharmaceuticals
- 4.970
- -0.270-5.15%
Close Apr 18 16:00 ET
- 4.950
- -0.020-0.40%
Post 19:41 ET
285.96MMarket Cap124.25P/E (TTM)
5.245High4.890Low3.86MVolume5.160Open5.240Pre Close19.29MTurnover7.42%Turnover Ratio124.25P/E (Static)57.54MShares7.00052wk High0.52P/B258.67MFloat Cap3.29552wk Low--Dividend TTM52.05MShs Float33.440Historical High--Div YieldTTM6.78%Amplitude0.450Historical Low4.999Avg Price1Lot Size
Vanda Pharmaceuticals Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -59.98%12.8M | -139.63%-3.73M | -115.97%-2.05M | -332.54%-13.22M | 686.04%31.8M | -50.19%31.98M | -64.61%9.42M | 36.61%12.84M | -70.11%5.69M | -55.99%4.05M |
| Net income from continuing operations | -60.02%2.51M | -134.98%-2.4M | -95.81%137K | -40.95%1.52M | 150.58%3.25M | -81.07%6.28M | -3.07%6.86M | -57.92%3.27M | -73.33%2.57M | -174.34%-6.43M |
| Operating gains losses | --655K | --0 | --0 | --0 | --655K | ---- | ---- | ---- | ---- | ---- |
| Depreciation and amortization | 10.14%3.01M | 74.66%1.16M | -14.45%580K | -12.75%602K | -4.56%670K | -3.80%2.73M | -6.09%663K | -4.24%678K | -3.09%690K | -1.82%702K |
| Deferred tax | -213.81%-1.29M | -1,894.72%-7.48M | 248.56%2.73M | 177.93%1.46M | -54.40%2.01M | -83.25%1.13M | -68.24%417K | -172.72%-1.84M | -206.93%-1.87M | 280.78%4.42M |
| Other non cash items | 39.21%3.42M | -23.34%647K | 45.68%928K | 73.76%735K | 100.91%1.11M | 42.13%2.46M | 66.80%844K | 14.57%637K | 14.02%423K | 87.12%552K |
| Change In working capital | -112.30%-747K | 309.04%2.82M | -192.12%-6.78M | -16,615.79%-18.83M | 44,180.00%22.04M | 121.92%6.07M | -110.35%-1.35M | 212.35%7.36M | -94.98%114K | 99.17%-50K |
| -Change in receivables | 35.08%-707K | -18.79%-4.84M | 829.85%4.33M | -662.42%-9.1M | 354.83%8.9M | 55.89%-1.09M | -145.16%-4.07M | 86.58%-593K | 128.99%1.62M | 231.96%1.96M |
| -Change in inventory | 82.79%-771K | 62.21%-427K | 68.65%-554K | 133.75%136K | 106.28%74K | -100.58%-4.48M | -1,367.53%-1.13M | -123.67%-1.77M | 71.38%-403K | -2,907.14%-1.18M |
| -Change in prepaid assets | 238.90%8.52M | 108.59%7.19M | -275.12%-7.19M | -751.36%-2.82M | 184.92%11.35M | -392.06%-6.14M | 104.57%3.45M | 398.11%4.11M | 79.36%-331K | -26,820.00%-13.36M |
| -Change in payables and accrued expense | -193.14%-10.98M | 201.65%3.33M | -120.93%-280K | -1,160.13%-3.24M | -180.37%-10.79M | 287.93%11.79M | -250.32%-3.28M | 4,878.57%1.34M | -95.03%306K | 354.67%13.43M |
| -Change in other working capital | -46.67%3.19M | -166.21%-2.44M | -172.06%-3.08M | -253.35%-3.8M | 1,499.44%12.51M | 6.00%5.99M | 1,507.86%3.68M | 6,374.24%4.27M | -122.88%-1.08M | -237.75%-894K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -59.98%12.8M | -139.63%-3.73M | -115.97%-2.05M | -332.54%-13.22M | 686.04%31.8M | -50.19%31.98M | -64.61%9.42M | 36.61%12.84M | -70.11%5.69M | -55.99%4.05M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -124.15%-12.06M | -158.05%-43.78M | 262.22%35.33M | -1,208.21%-190.89M | 1,623.67%187.29M | 165.09%49.93M | 390.13%75.43M | -31.28%-21.78M | 57.31%-14.59M | 15,204.23%10.87M |
| Net PPE purchase and sale | 43.59%-383K | 3.80%-253K | 83.78%-24K | 71.50%-55K | 32.00%-51K | -23.01%-679K | -96.27%-263K | -1,580.00%-148K | 35.23%-193K | 42.31%-75K |
| Net business purchase and sale | ---100.67M | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Net investment purchase and sale | 75.86%88.99M | -24.52%57.14M | 263.44%35.35M | -1,225.36%-190.84M | 1,612.32%187.35M | 166.46%50.6M | 392.65%75.69M | -30.31%-21.63M | 57.50%-14.4M | 5,343.28%10.94M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -124.15%-12.06M | -158.05%-43.78M | 262.22%35.33M | -1,208.21%-190.89M | 1,623.67%187.29M | 165.09%49.93M | 390.13%75.43M | -31.28%-21.78M | 57.31%-14.59M | 15,204.23%10.87M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 0 | 0 | 0 | -79.32%734K | -41.88%605K | -98.92%4K | ||||
| Proceeds from stock option exercised by employees | --0 | --0 | --0 | ---- | ---- | -79.32%734K | -41.88%605K | -98.92%4K | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | --0 | --0 | --0 | ---- | ---- | -79.32%734K | -41.88%605K | -98.92%4K | ---- | ---- |
| Net cash flow | ||||||||||
| Beginning cash position | 157.65%135.5M | 268.30%183.66M | 156.21%150.5M | 425.82%354.64M | 157.65%135.5M | -14.64%52.59M | -2.30%49.87M | 1.59%58.74M | -7.24%67.45M | -14.64%52.59M |
| Current changes in cash | -99.10%745K | -155.61%-47.52M | 472.39%33.28M | -2,224.23%-204.11M | 1,369.27%219.1M | 1,025.25%82.64M | 5,078.73%85.45M | -31.03%-8.94M | 40.96%-8.78M | 34.19%14.91M |
| Effect of exchange rate changes | -82.26%47K | -18.03%150K | -303.33%-122K | -132.91%-26K | 178.95%45K | 391.21%265K | 281.19%183K | 53.85%60K | 664.29%79K | -280.00%-57K |
| End cash Position | 0.58%136.29M | 0.58%136.29M | 268.30%183.66M | 156.21%150.5M | 425.82%354.64M | 157.65%135.5M | 157.65%135.5M | -2.30%49.87M | 1.59%58.74M | -7.24%67.45M |
| Free cash flow | -60.33%12.42M | -143.54%-3.99M | -116.34%-2.07M | -341.72%-13.28M | 699.60%31.75M | -50.83%31.31M | -65.43%9.15M | 34.89%12.69M | -70.66%5.49M | -56.18%3.97M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
